Search - tctmd.com

Displaying 1 - 20 of 88

Sort: Relevancy | Date

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Presentation TVT 2022

When to Consider Mitral Valve Replacement

Presenter: Gorav Ailawadi

June 10, 2022

Presentation TVT 2022

When to Still Consider Mitral TEER "On the Indication Edges"

Presenter: Saibal Kar

June 10, 2022

Presentation TVT 2022

Who Are the Optimal Functional MR Patients for Mitral TEER: Anatomic and Clinical Considerations

Presenter: Vratika Agarwal

June 10, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

A Concise Review of Right Atrial, Right Ventricular, and Pulmonary Arterial Properties in the Setting of Tricuspid Regurgitation

Presenter: Michael Brener

June 10, 2022

Presentation TVT 2022

TAVR Unload

Presenter: Nicolas Van Mieghem

June 10, 2022

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

RELIEVE HF: Different Patient Selection and Study Design – Should We Expect Different Results?

Presentation TVT 2022

Less Invasive Ventricular Enhancement for HFrEF

Presenter: John Boehmer

June 10, 2022

Presentation TVT 2022

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

Presenter: Chetan Huded

June 10, 2022

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Advertisement

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

When to Consider Mitral Valve Replacement

When to Still Consider Mitral TEER "On the Indication Edges"

Who Are the Optimal Functional MR Patients for Mitral TEER: Anatomic and Clinical Considerations

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

A Concise Review of Right Atrial, Right Ventricular, and Pulmonary Arterial Properties in the Setting of Tricuspid Regurgitation

TAVR Unload

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Less Invasive Ventricular Enhancement for HFrEF

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

What (Else) Have We Learned From REDUCE-LAP II?

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content